S&P 500
5.266,95 -39,09 (-0,74%) Nasdaq
16.920,58 -99,30 (-0,58%) NIKKEI 225
37.767,28 -789,59 (-2,05%) Dólar/Euro
1,0803 -0,0005 (-0,04%) Petróleo Brent
83,63 +0,03 (+0,04%) Bitcoin EUR
62.632,45 -900,41 (-1,42%)
JD Health International Inc. (6618.HK)
JD Health International Inc.
Jingdong Headquarters
Block C, Building 2 No. 20 Kechuang 11 Street, Daxing Dist. Yizhuang Eco. and Tech Development Zone
Beijing 101111
China
https://ir.jdhealth.com
Sector(es): Healthcare
Sector: Medical Care Facilities
Empleados a tiempo completo: 3118
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Enlin Jin | CEO & Executive Director | 2,11M | N/A | 1981 |
| Ms. Deng Hui | Chief Financial Officer | N/A | N/A | 1987 |
| Mr. Ming King Chiu FCIS, FCS | Company Secretary | N/A | N/A | 1977 |
Descripción
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Gobierno corporativo
El ISS Governance QualityScore de JD Health International Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
